MARC BOYER: Open Payments
NPI 1912090838 · BELLEVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,058 in 124 payments from 30 companies in 2025. Trend: 2023 $407 · 2024 $776 · 2025 $2,058
Food & beverage: $2,058
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $321 |
| Novo Nordisk Inc | 14 | $214 |
| AstraZeneca Pharmaceuticals LP | 9 | $202 |
| Lilly USA, LLC | 10 | $188 |
| PFIZER INC. | 20 | $172 |
| Amgen Inc. | 9 | $144 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $98 |
| Teva Pharmaceuticals USA, Inc. | 5 | $80 |
| GlaxoSmithKline, LLC. | 4 | $75 |
| Axsome Therapeutics, Inc. | 2 | $54 |
Products named: NURTEC ODT, FARXIGA, MOUNJARO, CREON, VRAYLAR, Kerendia, Rybelsus, OTEZLA.
Industry payments across IL — which companies pay providers there.
